Recent studies have shown that the CDCA gene family proteins (CDCA2, CDCA3, CDCA4, CDCA5, CDCA7, CDCA8) may serve as potential prognostic and therapeutic targets for CRC [42]. This evidence concerns the gene CDCA5 and colorectal carcinoma.